Shore Capital Reiterates Buy Rating for Ideagen (LON:IDEA)

Ideagen (LON:IDEAGet Rating)‘s stock had its “buy” rating reiterated by analysts at Shore Capital in a research report issued to clients and investors on Monday, MarketBeat reports.

Separately, Canaccord Genuity Group restated a “buy” rating and set a GBX 365 ($4.56) price objective on shares of Ideagen in a report on Wednesday, February 9th.

LON IDEA opened at GBX 356 ($4.45) on Monday. The stock has a market cap of £1.05 billion and a PE ratio of 177.81. The company has a debt-to-equity ratio of 40.85, a quick ratio of 0.80 and a current ratio of 0.80. The firm has a 50-day moving average of GBX 228.28 and a 200-day moving average of GBX 254.98. Ideagen has a 52-week low of GBX 195 ($2.44) and a 52-week high of GBX 360 ($4.50).

In other news, insider Alan Carroll sold 3,274 shares of Ideagen stock in a transaction on Monday, February 28th. The stock was sold at an average price of GBX 222 ($2.77), for a total transaction of £7,268.28 ($9,079.68).

About Ideagen (Get Rating)

Ideagen plc develops and sells information management software in the United Kingdom, the United States, Europe, and internationally. Its governance, risk, and compliance (GRC) solutions include Q-Pulse QMS, a quality management software; Q-Pulse PM, a product management software; Q-Pulse Law, an EHS legal compliance software; Q-Pulse WorkRite, a health and safety management system; Pentana Audit, an audit automation software; Pentana Disclose, a financial disclosure checklist software; Pentana Compliance, an accountability and competency compliance software; and Pentana Risk, a cloud-based performance and risk management software.

Further Reading

Receive News & Ratings for Ideagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ideagen and related companies with MarketBeat.com's FREE daily email newsletter.